Protocol Review (CRC)

方案审查 (CRC)

• 批准号: 8559786
• 负责人: Charles M. Rudin
• 金额: $ 8.1万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8559786
• 关键词: Cancer Center; Cancer Center Support Grant; Clinical Research; Comprehensive Cancer Center; Guidelines; Institutional Review Boards; Monitor; National Cancer Institute; Performance; Protocols documentation; Research; Review Committee; Role; System; authority; human subject; meetings; oncology

The Protocol Review and Monitoring System Clinical Research Review Committee (PRMS-CRC) of the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins is responsible for reviewing the scientific merit, priorities, and progress of the clinical research of the Center. Committee approval is required prior to opening a protocol in the Cancer Center. The Committee also has the authority to close protocols that do not demonstrate adequate scientific progress. On average, in 2010 each week the Committee reviewed three new studies, one resubmitted study with PRMS-CRC recommended changes, and two studies for annual progress and performance. The CRC is our Protocol Review and Monitoring System (PRMS).

约翰·霍普金斯（Johns Hopkins）Sidney Kimmel综合癌症中心（SKCCC）的协议审查和监测系统临床研究审查委员会（PRMS-CRC）负责审查该中心临床研究的科学功绩，优先事项和进步。在癌症中心开设一项方案之前，需要批准委员会批准。该委员会还有权关闭未表现出足够科学进步的协议。平均而言，2010年，委员会审查了三项新研究，一项对PRMS-CRC建议进行的重新提交研究，以及两项针对年度进步和绩效的研究。 CRC是我们的协议审查和监视系统（PRMS）。